3:30–5 pm Friday, January 12

NIC: Steps Closer to Human Brain Machine Interfaces

Key tenets in improving neuromodulatory efficacy for existing or novel usage is to delineate how this approach affects cell and network activity and identify optimal stimulation targets and settings. Preclinical studies can aid in these endeavors.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe how brain-machine interface or cortical microstimulation is employed to inform us of neural circuit activity and disease conditions.
  • Identify some of the basic neuroscience techniques used in preclinical studies to unmask novel deep brain stimulation targets for neurological conditions.
  • Explain how alternative deep brain stimulation targets can improve motor function and posture.
Read more...
10:30 am–Noon Friday, January 12

Plenary Session II: Next Generation Neuroscience

We will discuss how understanding of brain health, scientific advances, and wearables may improve neuromodulation as we know it. This plenary session provides an in-depth look at the newest neuromodulation technologies.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe how scientific advances will shape neuromodulation devices of the future.
  • Examine the potential impact of wearables in neuromodulation.
  • Illustrate how optimization of baseline brain functions may improve opportunity to use neuromodulatory devices.
Read more...
8–10 am Friday, January 12

Plenary Session I: Expand Our Minds in Neuroscience

An ever-expanding understanding of neural pathways is what continues to allow for the development, implementation, and enhancement of neuromodulatory therapies. This plenary session will explore how an understanding of neural pathways continues to allow us to implement and enhance neuromodulatory therapies in an accurate and safe manner.

Learning Objectives:

Upon completion of this educational activity, participants should be able to:

  • Explain the evidence suggesting that intraoperative monitoring should be the standard of care in SCS implantation.
  • Describe the neural mechanism that underlies the placebo effect.
  • Discuss spinal cord stimulation for spinal cord injury.
Read more...
Venue:
Room Name
Speaker:

Kiran V. Patel, MD

Peter Konrad, MD PhD

Subscribe to this RSS feed

Faculty subject to change.